Treatment progress of T1N1M0 renal cell carcinoma

吴恭瑾,秦泽,马俊海,常宏,岳中瑾
DOI: https://doi.org/10.13201/j.issn.1001-1420.2017.05.008
2017-01-01
Journal of Clinical Urology
Abstract:Renal cell carcinoma (RCC),as a common malignant tumor of urinary system,accounts for about 2%-3 % of all malignant tumors.Over the past two decades the incidence of RCC increased by about 2% worldwide,and was especially higher in developed countries,which makes it of great importance to explore the biological characteristics of RCC and take the most appropriate treatment with the right diagnosis.With the comprehensive progress of imaging diagnosis and surgical techniques,the number of early diagnosed T1 stage RCC is increasing by accidentally physical examination,and the related treatment and prognosis is also getting substantial improvement.In spite of this,some studies show that there are still a few patients diagnosed as T1 stage RCC found with lymph node metastasis or distant metastasis.In this paper,we review the treatment progress of T1 N1 M0 RCC with recent literature.
What problem does this paper attempt to address?